Real-life effectiveness and tolerability of perampanel in pediatric patients aged 4 years or older with epilepsy: A korean national multicenter study

Su Kyeong Hwang, Yun Jin Lee, Sang Ook Nam, Won Seop Kim, Jon Soo Kim, Sun Jun Kim, Yun Jeong Lee, Soonhak Kwon

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Background and Purpose The US Food and Drug Administration approval for perampanel has only recently been expanded to patients as young as 4 years, and so there have been few real-life studies of the effects of perampanel in pediatric patients. The aim of this study was to determine the long-term efficacy, factors affecting treatment response, and tolerability of perampanel as an add-on therapy in pediatric patients aged 4 years or older with epilepsy. Methods This multicenter retrospective observational study collected data from pediatric epilepsy centers of four Korean national universities. Changes in the seizure frequency from baseline, adverse events, and retention rates were obtained at 3, 6, and 12 months. Adverse events and discontinuation profiles were obtained to assess tolerability. Results This study included 220 children and adolescents (117 males and 103 females) aged 4 to 20 years. The overall response rate was 43.6%, and the seizure-freedom rate was 17.7%. Factors affecting a good treatment response were the absence of intellectual disability, small number of concomitant antiepileptic drugs, and low baseline seizure frequency. Eighty-eight patients (40%) experienced adverse events, but they mostly were of mild severity and resolved after the dose reduction or discontinuation of perampanel. The retention rates at 3, 6, and 12 months were 85.0%, 71.8%, and 50.5%, respectively. Conclusions Adjunctive treatment with perampanel was efficacious and tolerated in pediatric patients aged 4 years or older with epilepsy. Early perampanel treatment may help to reduce the burden of their seizures and improve their quality of life.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalJournal of Clinical Neurology (Korea)
Volume16
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • Adverse drug reactions
  • Children
  • Treatment efficacy
  • ‌Perampanel

Fingerprint

Dive into the research topics of 'Real-life effectiveness and tolerability of perampanel in pediatric patients aged 4 years or older with epilepsy: A korean national multicenter study'. Together they form a unique fingerprint.

Cite this